Immunology Respiratory Research Immunology Respiratory Research Find out more about our research and development in Immunology & Respiratory diseases
Immunology Immunology We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in immunology.
SIRPα Cancer Immunology Research SIRPα Cancer Immunology Research Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Oncology and Cancer Immunology Research Oncology and Cancer Immunology Research Find out more about our research and development in oncology and cancer immunology.
Agreement-to-acquire-Labor-Dr.-Merk Agreement-to-acquire-Labor-Dr.-Merk Boehringer Ingelheim to acquire Labor Dr. Merk & Kollegen to strengthen its next generation cancer immunology program
Four Pillars Cancer Immunology Four Pillars Cancer Immunology Boehringer Ingelheim is focusing cancer immunology research on T cell engagers, cancer vaccines, oncolytic viruses and immune & stromal modulation
Oncology Oncology We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in oncology.
Acquisition expands research in cancer immunology Acquisition expands research in cancer immunology Boehringer Ingelheim acquires Abexxa to develop novel cancer therapies by leveraging Abexxa’s unique technology and breakthrough antibody-based drugs.
Translational Medicine in Immunology Translational Medicine in Immunology Find out how translational medicine is helping bring transformational therapies to patients
Boehringer Ingelheim advances SIRP immune-oncology program Boehringer Ingelheim advances SIRP immune-oncology program Boehringer and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371
Our transformative team culture Our transformative team culture The immunology team is grounded in three key elements: Curiosity, creativity and courage. Hear about the culture at Boehringer Ingelheim.
Disentangling fibrosis Disentangling fibrosis Fibrosis is an important area of research for Boehringer Ingelheim that is focusing on fibrotic conditions of the liver, lung, kidney, skin and gut.
Collaboration-with-OxfordBioTherapeutics Collaboration-with-OxfordBioTherapeutics Boehringer Ingelheim collaborates with Oxford BioTherapeutics to discover tumor targets to deliver first-in-class treatments for cancer patients.
Trailr2-cdh17-antibody-phase1-trial Trailr2-cdh17-antibody-phase1-trial Boehringer Ingelheim advances a bi-specific therapeutic antibody to first-in-human clinical trial for patients with advanced gastrointestinal cancers
Lung Repair & Regeneration Video Lung Repair & Regeneration Video Lung repair & regeneration research addresses fundamental changes to lung architecture and how these changes impact lung function.
Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP
Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf